Yeshavanth Kumar Banasavadi Siddegowda, Ph.D.

Staff Scientist
A man stands outdoors in front of a modern building, wearing a gray jacket and a checkered shirt, with greenery in the background.
Division
Division of Intramural Research
Contact
yesh.banasavadisiddegowda@nih.gov
301-451-0970/Fax: 301-402-0380

Dr. Banasavadi is a Staff Scientist in the Surgical Neurology Branch who leads the Molecular Therapeutics Unit.

Research Interests

The foundation for the development of effective cancer therapeutics depends on hypothesis-driven basic science research and its translation to clinical endeavors. Glioblastoma (GBM) is the most common malignant primary brain tumor. It remains incurable despite aggressive, multimodal therapy and has proven to be an enduring challenge. In the Molecular & Therapeutics Unit, we extensively study the pathophysiology of GBM in the context of potential therapeutic candidates using preclinical in vivo and in vitro GBM models.

Our lab has three major goals:

  1. Identify and validate novel therapeutic targets for GBM.
  2. Develop biological and/or small molecule agents to target the validated therapeutic candidates.
  3. Drug repurposing.

Lab Members

Current Team

  • Ashis Chowdhury, BAMS, Research Biologist
  • Xiang Wang, BS, M.S., Research Biologist
  • Shumpei Onishi, M.D., Ph.D., Visiting Fellow

Lab Alumni

  • Hannah Sur, B.S., Medical Student at Quinnipiac University
  • Sriya Namagiri, B.S., Medical Student at St. George's University
  • Jean-Paul Bryant, M.D., MPH, M.S., Neurosurgery resident at MedStar Georgetown University Hospital
  • Sarah Rivas, B.S., Post-Bac IRTA
  • Aimee Dowling, B.S., Post-Bac IRTA
  • Celine Ertekin, SIP